Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today reported financial results for the second ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

Sarepta reported a quarter-on-quarter dip in sales for its Duchenne gene therapy. Elsewhere, Jazz won FDA approval of a brain ...

Q2 2025 Earnings Call Transcript August 6, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.83836, ...

As July draws to a close, it's time to take a look at what's in store in the health and wellness space over the upcoming weeks.August, the last month of summer, includes several ...

In 2025, the Depo-Provera lawsuit is real and legitimate. Millions have used it — but the risk of brain tumors was only ...

A well-known injectable birth control method is under fire after multiple studies linked it to a specific kind of brain tumor, and now, lawsuits are piling up against the drugmaker. […] The post ...

Currently, a multidistrict litigation against Pfizer (NYSE: PFE) is underway on behalf of women who claim to have developed meningiomas after receiving four or more consecutive injections of ...

A Cedar City family is going public with their 12-year-old daughter's brain cancer journey, a path they say is marked with both positive and negative experiences.

Woman, 30, diagnosed with brain tumor after telling her doctor about common symptom This circus performer found a brain tumor in the least predictable of ways ...

A couple sued two funeral homes for mishandling their son's remains after the pair allegedly received an unlabeled leaking box that contained a brain.